Chris Pacheco - Profile and Investment Details

Investor Profile

Chris Pacheco is a Venture Capital based in Boston, Massachusetts, United States with a diverse investment portfolio that includes companies such as KSQ Therapeutics, Noema Pharma, Quartet Health, Notarize, Cardurion Pharmaceuticals, NetRate Systems, Recurly, Armorblox, Amagma Therapeutics, FOLX Health, Kallyope, Vico Therapeutics, Faraday Pharmaceuticals, AgBiome, Metacrine, OM1, Alector, B2Gnow, Freenome, Mesodyne, Morphic Therapeutic, Adagio Therapeutics, Pandion Therapeutics, Montis Biosciences, AdimabCandesant Biomedical, ByHeart, Simon Data, Covetrus, Cyclerion Therapeutics, KenSci, Neogene Therapeutics, Lyra Therapeutics, Sesh, Agile BioFoundry, Africa Healthcare Network, Gauss Surgical, EGenesis, Wellthy, Tectonic Therapeutic, Quentis Therapeutics, Inc, TARIS Biomedical, Profitero, HighRes Biosolutions, Automotive Titling Company, Iora Health, ClearSky Data, BlackThorn Therapeutics, Keeps, Scholar Rock, Dewpoint Therapeutics, Foresight Mental Health, Caledonia Spirits, Sonrai Security, Auron Therapeutics, Aldebaran Therapeutics, Volastra Therapeutics, Ankyra, Quentis Therapeutics, Drizly, Amunix, Ajax Health, Kronos Bio, FidoCure, SQZ Biotech, Twistlock, Gossamer Bio, Thirty Madison, Dyno Therapeutics, Primmune Therapeutics, Pointy, Lyndra Therapeutics, FloQast, Jnana, SpineZone, Podimetrics, CAMP4 Therapeutics, IconOVir Bio, 1366 Technologies, Falkonry, Tausight, Nomad Health, Allstacks, . Over time, Chris Pacheco has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Chris Pacheco is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wellness, Women Founded, Immunotherapy, Engineering, Artificial Intelligence (AI), Information Technology (IT), Software, Manufacturing, Biotechnology, Drug Development, Neuroscience, Research, Health Diagnostics, Developer Tools, Medical, B2B, Therapeutics, Machine Learning, Pharmaceuticals, Oncology may find it worthwhile to explore potential connections with Chris Pacheco, as their portfolio suggests a familiarity and interest in this area.

Understanding Chris Pacheco’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.